Launo C, Gastaldo P, Piccardo F, Palermo S, Demartini A, Grattarola C
Section of Anesthesia and Intensive Care, Department of Surgery, Anesthesia and Transplants (DISCAT), School of Anesthesia and Intensive Care, University of Genoa, Genoa, Italy.
Minerva Anestesiol. 2003 Oct;69(10):751-60, 760-4.
Perioperative pain management in patients undergoing surgery is an essential target in order to improve intraoperative outcome and reduce postoperative complications occurrence. The combination of a local anesthetic with an opiate for epidural administration can ensure both analgesic effect (opiate) and neuroendocrine protection (local anesthetic). Levobupivacaine, S(-)-enantiomer form of bupivacaine, produces a sensitive-motor blockade similar to the racemate, with less cardiotoxicity; also ropivacaine is not cardiotoxic, but it has less anesthetic efficacy than levobupivacaine; both anesthetics could be administered through the epidural catheter in order to ensure adequate analgesia without any hemodynamic effects. Aim of our study was to evaluate a thoracic epidural analgesia for abdominal aortic surgery.
Through a randomized mono-blind study, involving 28 patients undergoing aortic surgery, we performed a clinical evaluation of 2 different perioperative thoracic epidural analgesic techniques; 2 different local anesthetics (levobupivacaine versus ropivacaine) in combination with the same opiate (fentanyl) were compared.
The results obtained show that both techniques ensure an excellent perioperative analgesia without any cardiotoxicity, with only moderate adverse effects due to opiate; the absence of postoperative mortality (within 30 days from operation) and the modest perioperative morbidity underline the qualities of this analgesic technique.
The combination of fentanyl with levobupivacaine or ropivacaine for use in thoracic epidural administration ensured both analgesic and neuroendocrine effect; significative differences between the 2 local anesthetics cannot be demonstrated, even if levobupivacaine, which presents a higher anesthetic efficacy, requires lower dosages.
对接受手术的患者进行围手术期疼痛管理是改善术中预后和减少术后并发症发生的重要目标。局部麻醉药与阿片类药物联合用于硬膜外给药可确保镇痛效果(阿片类药物)和神经内分泌保护作用(局部麻醉药)。左旋布比卡因是布比卡因的S(-)对映体形式,产生与消旋体相似的感觉-运动阻滞,心脏毒性较小;罗哌卡因也无心脏毒性,但麻醉效果比左旋布比卡因差;两种麻醉药均可通过硬膜外导管给药,以确保充分镇痛且无任何血流动力学影响。我们研究的目的是评估用于腹主动脉手术的胸段硬膜外镇痛。
通过一项随机单盲研究,纳入28例接受主动脉手术的患者,我们对2种不同的围手术期胸段硬膜外镇痛技术进行了临床评估;比较了2种不同的局部麻醉药(左旋布比卡因与罗哌卡因)与同一种阿片类药物(芬太尼)联合使用的情况。
所获得的结果表明,两种技术均能确保出色的围手术期镇痛且无任何心脏毒性,仅因阿片类药物产生中度不良反应;无术后死亡率(术后30天内)且围手术期发病率较低突显了这种镇痛技术的优点。
芬太尼与左旋布比卡因或罗哌卡因联合用于胸段硬膜外给药可确保镇痛和神经内分泌作用;即使左旋布比卡因麻醉效果更高且所需剂量更低,但两种局部麻醉药之间未显示出显著差异。